Filings

5 documents · 16 matches

1. LIMN Liminatus Pharma, Inc. 10-Q 2026-08-14

   Item 4. Controls and Procedures

   material weaknesses in its internal control over financial reporting. A material weakness is a deficiency, or combination of deficiencies, in a company
   3 matches in this document Show context Copy citation

2. LIMN Liminatus Pharma, Inc. 10-Q 2026-05-15

   Item 4. Controls and Procedures

   material weaknesses in its internal control over financial reporting. A material weakness is a deficiency, or combination of deficiencies, in a company
   3 matches in this document Show context Copy citation

3. LIMN Liminatus Pharma, Inc. 10-K 2026-03-31

   Item 9A. Controls and Procedures.

   material weaknesses in its internal control over financial reporting. A material weakness is a deficiency, or combination of deficiencies, in a company
   4 matches in this document Show context Copy citation

4. LIMN Liminatus Pharma, Inc. 10-Q 2025-11-14

   Item 4. Controls and Procedures

   material weaknesses in its internal control over financial reporting. A material weakness is a deficiency, or combination of deficiencies, in a company
   3 matches in this document Show context Copy citation

5. LIMN Liminatus Pharma, Inc. 10-Q 2025-10-06

   Item 4. Controls and Procedures

   material weaknesses in its internal control over financial reporting. A material weakness is a deficiency, or combination of deficiencies, in a company
   3 matches in this document Show context Copy citation